Skip to main content

Advertisement

Log in

Treatment of neurosyphilis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

In 2001, the incidence of primary and secondary syphilis increased in the United States for the first time in a decade. Increasing rates of early syphilis among men who have sex with men have been reported in many American cities, with similar outbreaks noted in Canada and Europe. In San Francisco, the increase has been particularly sharp and accompanied by an increase in the incidence of neurosyphilis. Early neurosyphilis develops within weeks to years of primary infection and primarily involves the meninges. Syndromes include syphilitic meningitis (often accompanied by cranial neuropathies), meningovascular syphilis (with associated ischemic stroke), or asymptomatic neurosyphilis. Late neurosyphilis occurs years to decades after exposure as cerebral or spinal gummatous disease or the classic parenchymal forms affecting the brain (general paresis or syphilitic encephalitis) or spinal cord and nerve roots (tabes dorsalis). Treponema pallidum, the causative agent, cannot be cultured in vitro, and microscopic techniques are laborious. Thus, diagnosis depends on serologic tests and cerebrospinal fluid (CSF) examination. The suboptimal sensitivity and specificity of these tests complicate diagnosis, particularly among patients coinfected with HIV. CSF examination should be performed to evaluate for neurosyphilis in all patients with positive serum syphilis serology and neurologic, ophthalmic, or tertiary disease, or in those who have failed therapy, and in HIVinfected patients with late latent syphilis or syphilis of unknown duration. Intravenous penicillin G is the recommended treatment for all forms of neurosyphilis and for syphilitic eye disease. An outpatient alternative, if adherence can be assured, is intramuscular benzathine penicillin with oral probenecid. Newer drugs that penetrate CSF, such as ceftriaxone or azithromycin, have not yet been adequately tested for neurosyphilis. Syphilis facilitates transmission of HIV (and vice versa), and thus all patients diagnosed with syphilis should be offered HIV testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Peterman TA, Heffelfinger JD, Swint EB, Groseclose SL: The changing epidemiology of syphilis. Sex Transm Dis 2005, 32(Suppl 10):S4-S10. This up-to-date review of syphilis epidemiology discusses the evolving epidemic, with an emphasis on the United States.

    PubMed  Google Scholar 

  2. Marra CM: Syphilis and human immunodeficiency virus--prevention and politics. Arch Neurol 2004, 61:1505–1508.

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention: Primary and secondary syphilis--United States, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:1117–1120.

  4. Hook EW, Peeling RW: Syphilis control--a continuing challenge. N Engl J Med 2004, 351:122–124. This succinct discussion of the global impact of syphilis emphasizes the need for simple, inexpensive, and effective testing and treatment.

    Article  PubMed  CAS  Google Scholar 

  5. San Francisco Department of Public Health: San Francisco sexually transmitted disease annual report, 2004. http://www.dph.sf.ca.us/reports/std/ sfstdannlsum2004.pdf. Accessed December 11, 2005.

  6. Zellan J, Augenbraun M: Syphilis in the HIV-infected patient: an update on epidemiology, diagnosis, and management. Curr HIV/AIDS Rep 2004, 1:142–147.

    Article  PubMed  Google Scholar 

  7. Buchacz K, Patel P, Taylor M, et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIVinfected patients with new syphilis infections. AIDS 2004, 18:2075–2079.

    Article  PubMed  Google Scholar 

  8. Lynn WA, Lightman S: Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004, 4:456–466.

    Article  PubMed  CAS  Google Scholar 

  9. Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 2003, 290:1510–1514. This concise review emphasizes the natural history, clinical features, and management of syphilis.

    Article  PubMed  CAS  Google Scholar 

  10. Zeltzer R, Kurban AK: Syphilis. Clin Dermatol 2004, 22:461–468.

    Article  Google Scholar 

  11. MarraCM: Neurosyphilis. Curr Neurol Neurosci Rep 2004, 4:435–440. This highly readable review interprets recent clinical research in the context of common clinical dilemmas.

    Article  PubMed  Google Scholar 

  12. Lukeheart SA, Hook EW, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862.

    Google Scholar 

  13. Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337:307–314.

    Article  PubMed  CAS  Google Scholar 

  14. O’Donnell JA, Emery CL: Neurosyphilis: a current review. Curr Infect Dis Rep 2005, 7:277–284.

    Article  PubMed  Google Scholar 

  15. Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatr 2004, 75:1727–1730.

    Article  PubMed  CAS  Google Scholar 

  16. Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161–167.

    Article  PubMed  Google Scholar 

  17. Pletcher SD, Cheung SW: Syphilis and otolaryngology. Otolaryngol Clin N Am 2003, 36:595–605.

    Article  Google Scholar 

  18. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002, 51:18–30. These guidelines, published every several years, include CDC recommendations for treatment of all forms of syphilis, including neurosyphilis, and indications for examination. New guidelines are due in the first quarter of 2006 and will be available at the CDC website, http://www.cdc.gov/std/treatment/, or at the Morbidity and Mortality Weekly Report website, http://www.cdc.gov/mmwr/.

    Google Scholar 

  19. Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005, 3:95–98.

    Article  PubMed  CAS  Google Scholar 

  20. MarraCM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369–376. This large study identified high serum VDRL titers and low CD4 count as risk factors for neurosyphilis.

    Article  PubMed  Google Scholar 

  21. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001–1006.

    Article  PubMed  Google Scholar 

  22. Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000, 30:540–544.

    Article  PubMed  CAS  Google Scholar 

  23. Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004, 63:85–88.

    PubMed  CAS  Google Scholar 

  24. Parkes R, Renton A, Meheus A, Laukamm-Josten U: Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004, 15:73–88.

    Article  PubMed  CAS  Google Scholar 

  25. Centers for Disease Control and Prevention: Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medical Association/Infectious Diseases Society of North America. MMWR Morb Mortal Wkly Rep 2004, 53:27–30.

    Google Scholar 

  26. Ali L, Roos KL: Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS Drugs 2002, 16:799–802.

    Article  PubMed  CAS  Google Scholar 

  27. Klasco RK: DRUGDEX® System. Greenwood Village, CO: Thomsom Micromedex; 2005.

    Google Scholar 

  28. Silberstein P, Lawrence R, Pryor D, Shnier R: A case of neurosyphilis with a florid Jarisch-Herxheimer reaction. J Clin Neurosci 2002, 9:689–690.

    Article  PubMed  CAS  Google Scholar 

  29. Pao D, Goh BT, Bingham JS: Management issues in syphilis. Drugs 2002, 62:1447–1461.

    Article  PubMed  CAS  Google Scholar 

  30. Centers for Disease Control and Prevention: Inadvertent use of Bicillin-CR to treat syphilis infection--Los Angeles, California, 1999–2004. MMWR Morb Mortal Wkly Rep 2005, 54:217–219.

    Google Scholar 

  31. Mullin P, Green G, Bakshi R: Special populations: the management of seizures in HIV-positive patients. Curr Neurol Neurosci Rep 2004, 4:308–314.

    Article  PubMed  Google Scholar 

  32. Lim ML, Min SS, Eron JJ, et al.: Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P450 induction. J Acquir Immune Defic Syndr 2004, 36:1034–1040.

    Article  PubMed  CAS  Google Scholar 

  33. Hugen PWH, Burger DM, Brinkman K, et al.: Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother 2000, 34:465–470.

    Article  PubMed  CAS  Google Scholar 

  34. Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328–332.

    Article  PubMed  CAS  Google Scholar 

  35. Centers for Disease Control and Prevention: Brief report: azithromycin treatment failures in syphilis infections--San Francisco, California, 2002–2003. MMWR Morb Mortal Wkly Rep 2004, 53:197–198.

    Google Scholar 

  36. Lukehart SA, Godornes C, Molini BJ, et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004, 251:154–158.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jay, C.A. Treatment of neurosyphilis. Curr Treat Options Neurol 8, 185–192 (2006). https://doi.org/10.1007/s11940-006-0009-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-006-0009-7

Keywords

Navigation